A sensitive solid-phase fluoroimmunoassay for detection of opiates in urine

Area of Science:

• Analytical Chemistry
• Biochemistry
• Toxicology

Background:

• Opiate urinalysis is crucial for clinical and forensic applications.
• Existing immunoassay techniques may require optimization for sensitivity and specificity.
• Development of rapid, sensitive, and specific assays for opiate detection is ongoing.

Purpose of the Study:

• To develop and validate a solid-phase competitive fluoroimmunoassay for the detection of opiates in urine.
• To adapt an automated flow fluorometer for kinetic binding analysis in immunoassay development.
• To assess the assay's sensitivity, specificity, and cross-reactivity with various opiates and metabolites.

Main Methods:

• Solid-phase competitive fluoroimmunoassay using polymer beads coated with anti-morphine monoclonal antibodies (MAbs).
• Fluorescein-conjugated morphine (FL-MOR) as the labeled hapten.
• Kinetic binding analysis on an automated flow fluorometer.
• Calibration curve constructed using Morphine-3-glucuronide (M3G).

Main Results:

• The assay demonstrated high sensitivity (0.2 ng/mL for M3G) and effective detection range (0.2–50 ng/mL).
• Morphine-3-glucuronide (M3G) showed effective competition, enabling calibration.
• Low cross-reactivity with methadone (<5%) and significant cross-reactivity with codeine, morphine-6-glucuronide, and oxycodone (>50%).
• Good agreement was observed with a commercial enzyme multiplied immunoassay technique in a clinical comparison of 205 urine samples.

Conclusions:

• The developed fluoroimmunoassay is a sensitive and specific method for opiate urinalysis.
• The assay's ability to use small sample volumes and its low cross-reactivity with methadone are advantageous.
• This single-step competitive assay shows promise for routine opiate screening.